$SSII

SS Innovations International, Inc. (SSII): Entry into a Material Definitive Agreement

SS Innovations International, Inc. (SSII) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 ea029521301ex1-1.htm ATM SALES AGREEMENT, DATED JUNE 18, 2026, BY AND BETWEEN SS INNOVATIONS INTERNATIONAL, INC AND VIRTU AMERICAS LLC Exhibit 1.1 EXECUTION VERSION SS INNOVATIONS INTERNATIONAL, INC. Common Stock (par value $0.0001 per share) ATM Sales Agreement June 18,

Original reporting
Published Jun 18, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 18, 2026, 8:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$SSII
Neutral
medium confidence
Mentioned
$SSII
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SSIINeutralMed
01

Why it matters

The company can issue and sell common stock through Virtu Americas under a Form S-3 registration framework, creating potential future share supply and dilution risk.

02

Market read

This is a new disclosed financing mechanism that can affect trading via dilution expectations, even though the excerpt does not state any immediate share issuance amount.

03

What to watch

The agreement’s impact depends on (1) the remaining capacity under the registration/prospectus supplement, (2) any stated use of proceeds (not included in the excerpt), and (3) whether the agent sells at-the-market during weak liquidity windows.

Relevance 6/10Novelty 6/10Timing: filed after-hours/late day (8-K filed 2026-06-18T16:06:31-04:00)

Background

The 8-K reports Item 1.01: entry into a material definitive agreement, specifically an ATM Sales Agreement dated June 18, 2026.

Company-level read

Ticker impact

$SSIINeutralMedium confidence
Context

SS Innovations entered an ATM sales agreement with Virtu Americas, enabling it to issue and sell common stock from time to time.

Expected impact

Near-term volatility possible as traders price potential future share issuance; direction depends on whether proceeds are viewed as value-accretive versus dilutive.

Evidence & confidence

An ATM agreement is a capital-markets tool; the 8-K confirms the agreement but does not specify issuance size or timing, limiting certainty on immediate price impact.

Market effects

Adds to the broader pattern of small/mid-cap issuers using ATMs for flexible funding; may modestly influence sentiment toward similar capital-needs names.

Primarily US-listed microcap/small-cap sentiment; limited direct regional spillover.

Low—this is company-specific financing mechanics with no stated global operational impact.

Counterpoint

Traders may view the ATM as optionality: the company can raise capital only if needed, so the market may not penalize the stock unless/ until actual sales occur.

Key entities

  • SS Innovations International, Inc.

    Subject of the 8-K; entered the ATM sales agreement to issue and sell common stock from time to time.

  • Virtu Americas LLC

    Sales agent/principal under the ATM agreement that facilitates issuance/sales of placement shares.

Related articles

$SSIIMed

SS Innovations Reports Second Quarter 2026 Financial Results

SS Innovations International, Inc. (SSII) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SS Innovations Reports Second Quarter 2026 Financial Results Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales FORT LAUDERDALE, FLA – August 13, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq:

$SSIILow

SS Innovations Announces Completion of World’s Longest-Distance Robotic Telesurgery

SS Innovations International (Nasdaq: SSII) said it completed a robot-assisted cardiac telesurgery between Georgetown, Guyana and Indore, India using its SSi Mantra system, covering about 12,500 miles (20,000 km) of fiber distance. The company said 22 cardiac telesurgeries have been done with SSi Mantra, and 173 telesurgeries globally; Guyana GA-FDD approved the system in May 2026.

$MDTMed

Medtronic (MDT) Commits $700 Million To Robotics As 2026 Impact Report Lands

Medtronic (MDT) announced a $700 million investment in its surgical robotics platform, part of a broader shift toward digital health and AI-driven care. The company released its 2026 Impact Report, outlining progress in AI tools, workforce goals, and environmental targets. Management aims to transform Medtronic into a multi-platform medtech group, focusing on robotics, data-driven care, and digital health.